Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency

Saved in:
Bibliographic Details
Published inFrontiers in Endocrinology Vol. 12
Main Authors Masashi Shimoda, Tomoatsu Mune, Hideaki Kaneto, Yukino Katakura, Kohei Kaku, Shuhei Nakanishi, Kenji Kohara, Tomohiko Kimura, Yuichiro Iwamoto, Fuminori Tatsumi, Yoshiro Fushimi, Junpei Sanada, Takashi Kusano
Format Journal Article
LanguageJapanese
Published Frontiers Media SA 12.10.2021
Subjects
Adrenocorticotropic Hormone
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
aseptic meningitis
Atrophy
destructive thyroiditis
Diseases of the endocrine glands. Clinical endocrinology
Endocrine System Diseases
Genetic Diseases, Inborn
Humans
Hypoglycemia
immune checkpoint inhibitor
Immune Checkpoint Inhibitors
immune-related adverse event
Ipilimumab
isolated ACTH deficiency
Japan
Male
Melanoma
Melanoma, Cutaneous Malignant
Meningitis, Aseptic
Middle Aged
Nivolumab
RC648-665
Skin Neoplasms
Thyroid Gland
Thyroiditis
Online AccessGet full text
ISSN1664-2392
DOI10.3389/fendo.2021.722586

Cover

More Information
ISSN:1664-2392
DOI:10.3389/fendo.2021.722586